back

Polpharma Pharmaceutical Works


Markus Sieger

President of the Management Board

Markus Sieger holds a degree in Economics from the University of Applied Sciences for Business and Administration in Zurich. Since the mid-nineties he has built up a strong track record in successfully managing complex and strategic transactions in and outside of Poland.  He was successfully managing large M&A transaction and developing multinational ventures in the area of pharmaceutical and FMCG companies. He has already been involved in supervision and management of Polpharma Group as a member of the Supervisory Board of Polpharma, delegated to exercise individual supervision over the company since 2013. He has a considerable experience in supervising activities of both private and public companies, being a member of several supervisory boards. He  supported the strategic development of media companies in Poland while co-operating with TVN and Onet.

Bożenna Kozakiewicz

Vice President of the Management Board

A graduate of Chemistry Faculty at Warsaw University, has over 20 years of experience in the pharmaceutical industry, gained at a number of positions. Since 2000 she has been working for Polpharma. Presently, Ms Kozakiewicz serves as a Vice President of the Management Board of Polpharma SA Pharmaceutical Works and a Member of the Management Board of Polpharma Trade Office. She is in charge of strategic sourcing and business development

 

Rajmund I. Martyniuk

Vice President of the Management Board

Mr Martyniuk has been associated with the pharmaceutical industry for 16 years. He began his professional career with SmithKline Beecham. From 1999 to 2003 he worked for Pfizer, at first as a Sales Manager and subsequently as a Sales Director. In 2003 joined Astra Zeneca assuming the position of Sales Director; then became Director for Sales Force Efficiency and New Products Development. Since 2006 Mr Martyniuk has been associated with Polpharma. At first holding the position of Sales Director, since 2007 he has been responsible for the division of marketing of Rx medicines. In 2008 he was appointed as the Vice President of the Management Board of Polpharma Trade Office. Since January 2014 he serves as a President of the Management Board of Polpharma Trade Office. Mr Martyniuk is responsible for the overall commercial activities of Polpharma Group, both in Poland and in foreign markets. He participates in the activities of Programme Council of Polish National Sales Awards. He is a Member of the Supervisory Board in Polpharma Scientific Foundation and a Member of Akrikhin Directors Council. In February 2009 “Brief” magazine awarded him the title of “Sales and Marketing Man of the Year”. He is a medical doctor, graduated from Pomeranian Medical University, has an MBA degree.

Tomasz Moys

Vice President of the Management Board

Mr Moys graduated from Chemistry Faculty at Nicolaus Copernicus University in Toruń and holds an MBA degree jointly awarded by University of Gdańsk, Copenhagen Business School, Universiteit Antwerpen and Fachhochschule fur Technik und Wirtschaft Berlin. In 1989 he began his professional career at the then Starogard Pharmaceutical Works Polfa (later Pharmaceutical Works Polpharma SA) as a production foreman. From 1998 to 2001 he managed the Department of Quality Assurance and Control, playing a key role in the process of establishment, launch and validation of the most important manufacturing facility of Polpharma for production of solid medicines. Since 2002 Mr Moys has been the director of the largest operational unit – Pharma. In 2011 he became Director of the Industrial Operations Division, managing operations at Starogard, Sieradz and Duchnice plants. From 2012 he is responsible for all industrial operations of the Polpharma Group, in Poland and abroad. On April 20, 2012 he has also been appointed a Member of the Management Board of Polfa Warszawa S.A. Since May 2013 he has served as a President of the Management Board of Polfa Warszawa S.A.

 

Gertjan Noordermeer

Vice President of the Management Board

Graduateof the VU University Amsterdam.Has nearly 30 years of experience in work for international corporations in finance area. During his professional career he was CFO in AVEBE UA, being responsible for Finance, Tax, Treasury and ICT. He designed innovative growth plans and was responsible for cost optimization and export business ex Europe. For the last 8 years he worked in TevaPharmaceuticals Europe as CFO Europe. His responsibilities included supervision over finance in 36 countries, supporting company development in Europe by organic growth and acquisitions, post-merger integration, design and implementation of the new Finance organizational structure.

Sebastian Szymanek

Vice President of the Management Board

Involved professionally in the pharmaceutical industry for the past 21 years. His work experience includes both generic companies (AstaMedica, Lekam) and innovators (Fournier, AstraZeneca). Graduate of the University of Wrocław Faculty of Pharmacy, supplemented his business education at the School of Management and Finance in Wrocław, Polish Open University in Warsaw and London Business School. Employed at Polpharma since 2007. In 2014, he took the position of CEO in Poland. Serves also as a Member of the Management Board of Polpharma Biuro Handlowe. In 2012, he received the Polish National Sales Award (PNSA) in the Sales Manager of the Year category.

Hannes Teissl

Vice President of the Management Board

Hannes Teissl is an MBA by education. He has been associated with the pharmaceutical industry for over 20 years and has held several international management positions at Sandoz including the most recent ones Global Head of M&A, CEO Sandoz Germany, BU Head Biopharmaceuticals and Global Commercial Head of API & Out-licensing. In Polpharma he is responsible for Biopharmaceuticals, Contract Manufacturing and Sales, Marketing and Business Development in Fine Chemicals Business Unit.

Joerg Windisch

Vice President of the Management Board

Joerg Windisch, who holds a Ph.D. in biochemistry, is an experienced science and technology business leader highly competent in the development of biological medicines. For about 20 years he was a key manager at Sandoz Biopharmaceuticals, building up its R&D and manufacturing competence. He had a leading role in the development of the company’s biosimilars program. For the last several years at Sandoz Biopharmaceuticals he served as Chief Science Officer (CSO). From 2016 to 2017 he served as Chief Operating Officer (COO) of Affimed, a NASDAQ-traded biotech which develops novel immune cell engagers for the treatment of cancer.

Andrzej Dziuban

Member of the Management Board

He graduated from the Faculty of Management at the University of Gdańsk in 2003. Subsequently, in 2006, he completed postgraduate studies in Staff Management Psychology at the Faculty of Psychology at the University of Warsaw. He has been involved with Polpharma since 1990 — first as a pupil of the Company-run “Polfa” School and later as an employee in the Environmental Protection Division. In 2000, he was employed in the HR Department. Since June 2004, as the Coordinator of the HR Department, he has been working on the implementation of the Act on the Company Social Benefit Fund and of agreements related with servicing the employees of Zakłady Farmaceutyczne Polpharma S.A. In 2013, he was elected the employee representative in the Management Board of Zakłady Farmaceutyczne Polpharma S.A.